Dr Mayne noted manifest advantages of Factor VIII concentrates over cryoprecipitate, such as accurate calculated dosage to be given in small volume, associated with a decreased chance of clinical side effects. Read more about Dr Mayne noted manifest advantages of Factor VIII concentrates over cryoprecipitate, such as accurate calculated dosage to be given in small volume, associated with a decreased chance of clinical side effects.
Dr Mayne enquired with Dr Craske as to the relevance to haemophilia "he reminded us that the individuals cited in the paper were known to maintain their lifestyle by being paid blood donors, as was documented in the World in Action (1975) programme." Read more about Dr Mayne enquired with Dr Craske as to the relevance to haemophilia "he reminded us that the individuals cited in the paper were known to maintain their lifestyle by being paid blood donors, as was documented in the World in Action (1975) programme."
According to Dr Mayne, there was increasing evidence that NANB hepatitis was not as benign as had been thought but could progress from chronic persistent hepatitis to cirrhosis. Read more about According to Dr Mayne, there was increasing evidence that NANB hepatitis was not as benign as had been thought but could progress from chronic persistent hepatitis to cirrhosis.
Throughout the 1970s liver function tests performed on patients at Belfast Haemophilia Centre showed persistent abnormal liver function. Read more about Throughout the 1970s liver function tests performed on patients at Belfast Haemophilia Centre showed persistent abnormal liver function.
Hemofil was the commercial concentrate used in Belfast Haemophilia Centre Read more about Hemofil was the commercial concentrate used in Belfast Haemophilia Centre
Dr Mayne describing the history of haemophilia care in Northern Ireland, described patients as being "ecstatic" with the advent of cryoprecipitate which was "revolutionary". Read more about Dr Mayne describing the history of haemophilia care in Northern Ireland, described patients as being "ecstatic" with the advent of cryoprecipitate which was "revolutionary".
Dr Elizabeth Mayne became director of the Belfast Haemophilia Centre. Read more about Dr Elizabeth Mayne became director of the Belfast Haemophilia Centre.
At the meeting of the Haemophilia reference centre directors held on 14 September 1981, it was noted that the annual returns for 1980 showed that the amount of Factor VIII concentrates used, especially commercial materials, had again increased. Read more about At the meeting of the Haemophilia reference centre directors held on 14 September 1981, it was noted that the annual returns for 1980 showed that the amount of Factor VIII concentrates used, especially commercial materials, had again increased.
The Belfast Haemophilia Centre was established in 1958 but until 1981 it was included in the Oxford supra-region. Read more about The Belfast Haemophilia Centre was established in 1958 but until 1981 it was included in the Oxford supra-region.
Dr Forbes acknowledged in 1983 that there was the potential for locally sourced donors to bring contaminated blood with HIV into the donor pool. Read more about Dr Forbes acknowledged in 1983 that there was the potential for locally sourced donors to bring contaminated blood with HIV into the donor pool.